2m 2m 2m 2m 2m 2m 2m
Heron Therapeuti (HRTX)
NASDAQ
$0.32+$0.005 (+1.43%)
Price as of Sep 11, 2026 7:30 PM EDT- $59.9MMarket Cap
- -74.96%1-Year Change
- BiotechnologyIndustry
Heron Therapeuti (HRTX)
$0.32+$0.005 (+1.43%)
HRTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.32 | ||
Change | -$0.007 (-2.11%) | ||
Open | $0.33 | ||
High | $0.33 | ||
Low | $0.31 | ||
Previous Close | $0.32 | ||
Volume | 1,371,704 | ||
30-Day Average Volume | 2,218,351 | ||
1-Week Change | -8.26% | ||
1-Month Change | -2.56% | ||
1-Year Change | -74.96% | ||
3-Year Change | -74.76% | ||
5-Year Change | -97.29% | ||
Fundamentals | |||
Shares Outstanding | 189.9M | ||
Total Assets | $252.3M | ||
Market Cap | $59.9M | ||
Enterprise Value | $73.1M | ||
Period: QTR TTM FY | |||
Revenue | $37.7M | ||
Net Income | -$5.5M | ||
Free Cash Flow | -$2.4M | ||
EBIT | -$2.3M | ||
EBITDA | -$1.8M | ||
Net Working Capital | $137.7M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -40 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 9 | ||
P/E | -11 | ||
PEG | -0 | ||
Price/Free Cash Flow | -25 | ||
Price/Operating Cash Flow | -27 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue